NuVasive (NSDQ:NUVA) announced today that it launched its Reline 3D posterior fixation system for pediatric spinal deformities.
San Diego-based NuVasive’s latest addition to its spine portfolio is now commercially available around the globe for treating adolescent idiopathic scoliosis (AIS). The Reline 3D is designed to turn a multi-step technique into a holistic, single-plane correction to offer surgeons versatility, according to a news release.
Reline 3D is an extension of NuVasive’s fixation portfolio filled with Reline systems, including Reline Open, Reline MAS, Reline Trauma and Reline Small Stature. The latest version of the platform is commercially available within the U.S. and European markets now, and NuVasive expects availability in other countries next year.
“Reline 3D represents a true procedural solution that increases efficiencies and supports a less invasive approach to addressing complex pathologies,” NuVasive president Matt Link said in the release. “As an innovative leader in less invasive surgery, NuVasive is committed to providing industry-leading procedures and technologies that enable health systems and surgeons to provide the same standard of care while reducing operative time and length of stay in the hospital.
“With this launch of Reline 3D, we have expanded this commitment to the AIS patient population.”